SCOPUS 정보 검색 플랫폼

Volumn 75, Issue 16, 2001, Pages 7462-7469

Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients

(10) Kempf, D J a Isaacson, J D a King, M S a Brun, S C a Xu, Y a Real, K a Bernstein, B M a Japour, A J a Sun, E a Rode, R A a

a ABBOTT LABORATORIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR; LOPINAVIR PLUS RITONAVIR; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE MUTATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS GENOME; VIRUS ISOLATION; VIRUS RESISTANCE;

DRUG RESISTANCE; GENOME, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; PYRIMIDINONES;

EID: 0034909925 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/JVI.75.16.7462-7469.2001 Document Type: Article

Times cited : (221)

References (25)

1
- 0000133998
- An analysis of transformations
- (1964) J. R. Stat. Soc. Ser. B , vol.26 , pp. 211-243
- Box, G.E.P.¹ Cox, D.R.²

2
- 0031849665
- In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor
- (1998) J. Virol. , vol.72 , pp. 7532-7541
- Carrillo, A.¹ Stewart, K.² Sham, H.L.³ Norbeck, D.W.⁴ Kohlbrenner, W.E.⁵ Leonard, J.M.⁶ Kempf, D.J.⁷ Molla, A.⁸

3
- 0002815482
- Genetic correlates of virological response to an indinavir-containing salvage regimen in patients with nelfinavir failure
- (1999) Antiviral Ther. , vol.4 , Issue.SUPPL. 1 , pp. 44
- Condra, J.¹ Holder, J.J.² Schleif, W.A.³ Bakshi, K.⁴ Danovich, R.M.⁵ Graham, D.J.⁶ Shivaprakash, M.⁷ Holmes, K.⁸ Saah, A.J.⁹ Leavitt, R.Y.¹⁰ Chodakewitz, J.A.¹¹ Emini, E.A.¹²

4
- 0028943992
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
- (1995) Nature , vol.374 , pp. 569-571
- Condra, J.H.¹ Schleif, W.A.² Blahy, O.M.³ Gabryelski, L.J.⁴ Graham, D.J.⁵ Quintero, J.C.⁶ Rhodes, A.⁷ Robbins, H.L.⁸ Roth, E.⁹ Shivaprakash, M.¹⁰ Titus, D.¹¹ Yang, T.¹² Teppler, H.¹³ Squires, K.E.¹⁴ Deutsch, P.J.¹⁵ Emini, E.A.¹⁶

5
- 10344263394
- Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
- (1996) J. Virol. , vol.70 , pp. 8270-8276
- Condra, J.H.¹ Holder, D.J.² Schleif, W.A.³ Blahy, O.M.⁴ Danovich, R.M.⁵ Gabryelski, L.J.⁶ Graham, D.J.⁷ Laird, D.⁸ Quintero, J.C.⁹ Rhodes, A.¹⁰ Robbins, H.L.¹¹ Roth, E.¹² Shivaprakash, M.¹³ Yang, T.¹⁴ Chodakewitz, J.A.¹⁵ Deutsch, P.J.¹⁶ Leavitt, R.Y.¹⁷ Massari, F.E.¹⁸ Mellors, J.W.¹⁹ Squires, K.E.²⁰ more..

6
- 0032990266
- Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: Antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome
- (1999) J. Infect. Dis. , vol.179 , pp. 1375-1381
- Deeks, S.G.¹ Hellmann, N.S.² Grant, R.M.³ Parkin, N.T.⁴ Petropoulos, C.J.⁵ Becker, M.⁶ Symonds, W.⁷ Chesney, M.⁸ Volberding, P.A.⁹

7
- 0344593433
- The relation between baseline HIV drug resistance and response to antiretroviral therapy: Reanalysis of retrospective and prospective studies using a standardized data analysis plan
- (2000) Antiviral Ther. , vol.5 , pp. 41-48
- DeGruttola, V.¹ Dix, L.² D'Aquila, R.³ Holder, D.⁴ Phillips, A.⁵ Ait-Khaled, M.⁶ Baxter, J.⁷ Clevenbergh, P.⁸ Hammer, S.⁹ Harrigan, R.¹⁰ Katzenstein, D.¹¹ Lanier, R.¹² Miller, M.¹³ Para, M.¹⁴ Yerly, S.¹⁵ Zolopa, A.¹⁶ Murray, J.¹⁷ Patick, A.¹⁸ Miller, V.¹⁹ Castillo, S.²⁰ Pedneault, L.²¹ Mellors, J.²² more..

8
- 0029151345
- Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure
- (1995) Biochemistry , vol.34 , pp. 9282-9287
- Gulnik, S.V.¹ Suvoruv, L.I.² Liu, B.S.³ Yu, B.⁴ Anderson, B.⁵ Mitsuya, H.⁶ Erickson, J.W.⁷

9
- 0032750440
- Baseline HIV drug resistance profile predicts response to ritonavir-SQV protease inhibitor therapy in a community setting
- (1998) AIDS , vol.13 , pp. 1863-1871
- Harrigan, P.R.¹ Hertogs, K.² Verbiest, W.³ Pauwels, R.⁴ Larder, B.⁵ Kemp, S.⁶ Bloor, S.⁷ Yip, B.⁸ Hogg, R.S.⁹ Alexander, C.¹⁰ Montaner, J.S.¹¹

10
- 0344474694
- A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 269-276
- Hertogs, K.¹ Debethune, M.P.² Miller, V.³ Ivens, T.⁴ Schel, P.⁵ Vancauwenberge, A.⁶ Vandeneynde, C.⁷ Vangerwen, V.⁸ Azijn, H.⁹ Vanhoutte, M.¹⁰ Peeters, F.¹¹ Staszewski, S.¹² Conant, M.¹³ Bloor, S.¹⁴ Kemp, S.¹⁵ Larder, B.¹⁶ Pauwels, R.¹⁷

11
- 17344390474
- Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
- International AIDS Society - USA Panel
- (1998) JAMA , vol.279 , pp. 1984-1991
- Hirsch, M.S.¹ Conway, B.² D'Aquila, R.T.³ Johnson, V.A.⁴ Brun-Vezinet, F.⁵ Clotet, B.⁶ Demeter, L.M.⁷ Hammer, S.M.⁸ Jacobsen, D.M.⁹ Kuritzkes, D.R.¹⁰ Loveday, C.¹¹ Mellors, J.W.¹² Vella, S.¹³ Richman, D.D.¹⁴

12
- 0001944530
- Identification of clinically relevant phenotypic and genotypic breakpoints for ABT-378/r in multiple PI-experienced, NNRTI-naive patients
- (2000) Antiviral Ther. , vol.5 , Issue.SUPPL. 3 , pp. 70
- Kempf, D.¹ Brun, S.² Rode, R.³ Isaacson, J.⁴ King, M.⁵ Xu, Y.⁶ Real, K.⁷ Hsu, A.⁸ Granneman, R.⁹ Lie, Y.¹⁰ Hellmann, N.¹¹ Bernstein, B.¹² Sun, E.¹³

13
- 0019065897
- Assessing laboratory evidence for neoplastic activity
- (1980) Biometrics , vol.36 , pp. 381-399
- Mantel, N.¹

14
- 17544379494
- HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohort
- (2000) Antiviral Ther. , vol.5 , pp. 49-55
- Miller, V.¹ Cozzi-Lepri, A.² Hertogs, K.³ Gute, P.⁴ Larder, B.⁵ Bloor, S.⁶ Klauke, S.⁷ Rabenau, H.⁸ Phillips, A.⁹ Staszewski, S.¹⁰

15
- 15444377672
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
- (1996) Nat. Med. , vol.2 , pp. 760-766
- Molla, A.¹ Korneyeva, M.² Gao, Q.³ Vasavanonda, S.⁴ Schipper, P.J.⁵ Mo, H.-M.⁶ Markowitz, M.⁷ Chernyavskiy, T.⁸ Niu, P.⁹ Lyons, N.¹⁰ Hsu, A.¹¹ Granneman, G.R.¹² Ho, D.D.¹³ Boucher, C.A.B.¹⁴ Leonard, J.M.¹⁵ Norbeck, D.W.¹⁶ Kempf, D.J.¹⁷

16
- 0032566902
- Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus
- (1998) Virology , vol.250 , pp. 255-262
- Molla, A.¹ Vasavanonda, S.² Kumar, G.³ Sham, H.L.⁴ Johnson, M.⁵ Grabowski, B.⁶ Denissen, J.F.⁷ Kohlbrenner, W.⁸ Plattner, J.J.⁹ Leonard, J.M.¹⁰ Norbeck, D.W.¹¹ Kempf, D.J.¹²

17
- 0002117069
- Genotypic and phenotypic analysis of viral isolates from subjects with detectable viral load on therapy with ABT-378/ritonavir (ABT-378/r)
- (2000) Antiviral Ther. , vol.5 , Issue.SUPPL. 3 , pp. 30
- Molla, A.¹ Brun, S.² Mo, H.³ Real, K.⁴ Poddig, J.⁵ Bernstein, B.⁶ Hertogs, K.⁷ Larder, B.⁸ Lie, Y.⁹ Hellmann, N.¹⁰ Vasavanonda, S.¹¹ Chernyavskiy, T.¹² Freimuth, W.¹³ Japour, A.¹⁴ Sun, E.¹⁵ Kempf, D.¹⁶

18
- 17044457875
- ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naïve adults with HIV-1 infection: 48-week results
- (2001) AIDS , vol.15
- Murphy, R.L.¹ Brun, S.² Hicks, C.³ Eron, J.J.⁴ Gulick, R.⁵ King, M.⁶ White A.C., Jr.⁷ Benson, C.⁸ Thompson, M.⁹ Kessler, H.A.¹⁰ Hammer, S.¹¹ Bertz, R.¹² Hsu, A.¹³ Japour, A.¹⁴ Sun, E.¹⁵

19
- 0033827606
- Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333
- (2000) J. Infect. Dis. , vol.182 , pp. 733-743
- Para, M.F.¹ Glidden, D.V.² Coombs, R.W.³ Collier, A.C.⁴ Condra, J.H.⁵ Craig, C.⁶ Bassett, R.⁷ Leavitt, R.⁸ Snyder, S.⁹ McAuliffe, V.¹⁰ Boucher, C.¹¹

20
- 0034019566
- A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 920-928
- Petropoulos, C.J.¹ Parkin, N.T.² Limoli, K.L.³ Lie, Y.S.⁴ Wrin, T.⁵ Huang, W.⁶ Tian, H.⁷ Smith, D.⁸ Winslow, G.A.⁹ Capon, D.J.¹⁰ Whitcomb, J.M.¹¹

21
- 0029731556
- Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials - Compensatory modulations of binding and activity
- (1996) J. Biol. Chem. , vol.271 , pp. 31957-31963
- Schock, H.B.¹ Garsky, V.M.² Kuo, L.C.³

23
- 0022039941
- Testing the statistical certainty of a response to increasing doses of a drug
- (1985) Biometrics , vol.41 , pp. 295-301
- Tukey, J.W.¹ Ciminera, J.L.² Heyse, J.F.³

24
- 0031946007
- Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo
- (1998) J. Virol. , vol.72 , pp. 3300-3306
- Zennou, V.¹ Mammano, F.² Paulous, S.³ Mathez, D.⁴ Clavel, F.⁵

25
- 0033534115
- HIV-1 genotypic resistance patterns predict response to SQV-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed
- (1999) Ann. Intern. Med. , vol.131 , pp. 813-821
- Zolopa, A.R.¹ Shafer, R.W.² Warford, A.³ Montoya, J.G.⁴ Hsu, P.⁵ Katzenstein, D.⁶ Merigan, T.C.⁷ Efron, B.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.